Darifenacin, an M3 selective receptor antagonist, reduces the frequency of nocturnal awakening, an important symptom of overactive bladder

被引：5
|
作者：
Khullar, V
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37753-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [41] Expression of Muscarinic Receptor Subtypes (Effect of M3 Selective Antagonist on Gastric Motility and in Rat Gastric Smooth Muscle Emptying)
    Sheng Lin
    Masayoshi Kajimura
    Ken Takeuchi
    Makoto Kodaira
    Hiroyuki Hanai
    Eizo Kaneko
    Digestive Diseases and Sciences, 1997, 42 : 907 - 914
  • [42] The colon-selective muscarinic receptor antagonist otilonium bromide inhibits M3 acetylcholine receptors in human colonic crypts
    Williams, MR
    Lindqvist, SM
    Evangelista, S
    FASEB JOURNAL, 2001, 15 (04): : A558 - A558
  • [43] Selective M3 Muscarinic Receptor Antagonist Inhibits Small-Cell Lung Carcinoma Growth in a Mouse Orthotopic Xenograft Model
    Ami, Nozomi
    Koga, Kazumi
    Fushiki, Hiroshi
    Ueno, Yoko
    Ogino, Yoshio
    Ohta, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 116 (01) : 81 - 88
  • [44] Does a selective muscarinic receptor (M3) antagonist enhance the efficacy through oral delivery in chronic obstructive pulmonary disease patients?
    Naruganahalli, Krishna S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) : 1127 - 1130
  • [45] Co-expression of muscarinic receptor subtypes (M2/M3) and G protein coupled receptor kinase subtypes (GRK2/3/4) in the human urinary bladder detrusor muscle in the normal and obstructive bladder - A possible mechanism for overactive bladder
    Furuya, Y
    Kamiyama, M
    Zakoji, H
    Takihana, Y
    Araki, I
    Tanabe, N
    Takeda, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 37 - 37
  • [46] The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivation
    Yamanishi, T
    Chapple, CR
    Yasuda, K
    Chess-Willlams, R
    JOURNAL OF UROLOGY, 2002, 167 (01): : 397 - 401
  • [47] 19F solid-state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples
    Wenslow, RM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (05) : 555 - 561
  • [48] Synthesis of a muscarinic receptor (M3) antagonist via a ZN-catalyzed disastereoselective Michael reaction, a selective deoxyfluorination of a ketone and an ATE complex mediated magnesium-bromine exchange reaction.
    Mase, T
    Houpis, IN
    Akao, A
    Dorziotis, I
    Emerson, K
    Iida, T
    Itoh, T
    Kamei, K
    Kato, S
    Kato, Y
    Kawasaki, M
    Lang, FR
    Lynch, J
    Molina, A
    Nemoto, T
    Okada, S
    Reamer, R
    Song, ZJ
    Tschaen, D
    Wada, T
    Zewge, D
    Tomimoto, K
    Volante, S
    Reider, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U158 - U158
  • [49] SELECTIVE M(3)-RECEPTOR ANTAGONIST ZAMIFENACIN REDUCES COLONIC MOTILITY FOR 12 HOURS FOLLOWING MULTIPLE DOSING WITH NO EFFECT ON WHOLE GUT TRANSIT - A DOUBLE-BLIND-STUDY IN VOLUNTEERS
    WILLIAMS, SA
    FORSTER, PL
    DURNIN, CJ
    MCEWEN, J
    RAPEPORT, WG
    GASTROENTEROLOGY, 1993, 104 (04) : A602 - A602
  • [50] Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese SubjectsAn Open-Label, Single-Center, First-in-Human Study
    Luning Sun
    Li Ding
    Yongqing Wang
    Wenjia Zhou
    Zhengyu Yan
    Weilin Sun
    Hongwen Zhang
    Ning Ou
    Xiaoping Chen
    Drugs in R&D, 2012, 12 (1) : 17 - 28
12345